Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Probi AB (publ)    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
  • The company has poor fundamentals for a short-term investment strategy.
Strengths
  • The group's high margin levels account for strong profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • The stock is in a well-established, long-term rising trend above the technical support level at 260 SEK
Weaknesses
  • Technically, the stock approaches a strong medium-term resistance at SEK 472.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 52.61 times its estimated earnings per share for the ongoing year.
  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Sector Special Foods & Welbeing Products
1st jan.Capitalisation (M$)Investor Rating
PROBI AB (PUBL)11.61%640
BY-HEALTH CO., LTD.0.62%5 778
BALCHEM CORPORATION6.01%3 952
THE SIMPLY GOOD FOODS COMPA..-10.71%2 680
MEDIFAST, INC.6.23%2 444
BIOGAIA AB (PUBL)-6.15%1 216
JAMIESON WELLNESS INC.2.80%1 162
BLACKMORES LIMITED-5.74%1 071
BELLRING BRANDS, INC.-0.86%950
GRAPE KING BIO LTD-1.13%864
MIDSONA AB (PUBL)6.56%644
SIGMA HEALTHCARE LIMITED0.81%468
BURCON NUTRASCIENCE CORPORA..18.31%342
NOVAREX CO LTD--.--%276
FINE FOODS & PHARMACEUTICAL..3.33%235
CLOVER CORPORATION LIMITED-11.11%185
More Results
Financials
Sales 2020 711 M 84,9 M 84,9 M
Net income 2020 102 M 12,1 M 12,1 M
Net cash 2020 259 M 30,9 M 30,9 M
P/E ratio 2020 53,0x
Yield 2020 0,33%
Capitalization 5 367 M 640 M 641 M
EV / Sales 2020 7,18x
EV / Sales 2021 6,61x
Nbr of Employees -
Free-Float 39,3%
Upcoming event on PROBI AB (PUBL)
Notations Surperformance©
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability -
P/E ratio
Potential
Yield
Consensus -
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes